Financial Year |
March 31 2023 |
Monetary Funds |
19,887,000,000.00 |
Held-for-trading Financial Assets |
71,000,000.00 |
Notes Receivable |
-- |
Accounts Receivable |
1,649,000,000.00 |
Advances to Suppliers |
248,000,000.00 |
Other Receivables |
2,463,000,000.00 |
Amounts Due From Related Companies |
-- |
Interest Receivable |
-- |
Dividend Receivable |
-- |
Inventories |
1,698,000,000.00 |
Among: Consumptive Biological Assets |
-- |
Non-Current Assets Maturing Within One Year |
235,000,000.00 |
Other Current Assets |
5,842,000,000.00 |
Total Current Assets |
32,093,000,000.00 |
Available-for-Sale Financial Asset |
-- |
Held-to-maturity Investments |
-- |
Long-Term Account Receivable |
-- |
Long-term Equity Investment |
2,696,000,000.00 |
Investment Properties |
217,000,000.00 |
Fixed Assetes |
86,580,000,000.00 |
Under-construction Projects |
17,992,000,000.00 |
Construction Materials |
-- |
Disposal of Fixed Assets |
-- |
Capitalized Biological Assets |
-- |
Oil and Gas Assets |
-- |
Intangible Assets |
2,567,000,000.00 |
R&D expenses |
-- |
Goodwill |
9,028,000,000.00 |
Long-Term Deferred and Prepaid Expenses |
1,969,000,000.00 |
Deferred Income Tax Assets |
9,858,000,000.00 |
Other Non-Current Assets |
2,028,000,000.00 |
Sub-Total of Non-Current Assets |
256,414,000,000.00 |
Total Assets |
288,507,000,000.00 |
Short-Term Loans |
36,866,000,000.00 |
Trading Financial liabilities |
-- |
Notes Payable |
1,966,000,000.00 |
Accounts Payable |
15,325,000,000.00 |
Accounts Received In Advance |
48,000,000.00 |
Employee Compensation Payable |
2,552,000,000.00 |
Taxes Payable |
1,820,000,000.00 |
Interest Payable |
-- |
Dividend Payable |
-- |
Other payables |
3,739,000,000.00 |
Due to Related Companies |
-- |
Non-Current Liabilities Due Within One Year |
29,171,000,000.00 |
Other Current Liabilities |
10,182,000,000.00 |
Sub-Total of Current Liabilities |
106,280,000,000.00 |
Long-term Loans |
50,881,000,000.00 |
Bonds Payable |
19,578,000,000.00 |
Long-Term Accounts Payable |
987,000,000.00 |
Special Payable |
-- |
Estimatied Liabilities |
8,147,000,000.00 |
Deferred Income Tax Liabilities |
-- |
Other Non-Current Liabilities |
1,110,000,000.00 |
Sub-Total of Non-Current Liabilities |
156,189,000,000.00 |
Total Liabilities |
262,469,000,000.00 |
Paid-In Capital(Or Share Stock) |
22,291,000,000.00 |
Capital Surplus |
53,488,000,000.00 |
Surplus Reserve |
782,000,000.00 |
LESS:Treasury Stock |
-- |
Undistributed Profits |
-48,330,000,000.00 |
Minority Stockholder's Interest |
825,000,000.00 |
Foreign Currency Capital |
-- |
Abnormal Management Project Income Adjusted |
-- |
Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
25,213,000,000.00 |
Owner's Equity(Stockholder's Equity) |
26,038,000,000.00 |
Total Liabilities and Owner's Equity(Stockholder's Equity) |
288,507,000,000.00 |